Trademark: 90523038
Word
LYMPHOMAP
Status
Registered
Status Code
700
Status Date
Tuesday, April 9, 2024
Serial Number
90523038
Registration Number
7355878
Registration Date
Tuesday, April 9, 2024
Mark Type
4000
Filing Date
Wednesday, February 10, 2021
Published for Opposition
Tuesday, October 19, 2021

Trademark Owner History
LYMPHOMAP Inc. - Owner At Publication
LYMPHOMAP, Inc. - Original Applicant

Classifications
9 Downloadable computer programs using artificial intelligence for use in software development and machine learning in the field of healthcare; Recorded computer software using artificial intelligence for use in software development and machine learning in the field of healthcare; Software as a Medical Device (SaMD), downloadable, for diagnosing and treating cancer; Software as a Medical Device (SaMD), recorded, for diagnosing and treating cancer
38 Videoconferencing services
35 Business collaboration services, namely, providing a national computer-based networking web site for health care and medical researchers and educators to collaborate across disciplines to help improve health care education and medical education; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences
44 Medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions
42 Application service provider (ASP) featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Medical and scientific research in the field of cancer treatment and diagnosis; Providing online non-downloadable computer programs for use in cancer diagnosis; Providing a website featuring non-downloadable software using artificial intelligence for use in software development and machine learning in the field of healthcare; Providing information about medical and scientific research via a website; Providing on-line non-downloadable software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Technology consultation in the field of artificial intelligence

Trademark Events
Apr 9, 2024
Registered-Principal Register
Apr 9, 2024
Notice Of Registration Confirmation Emailed
Apr 9, 2024
Notice Of Registration Confirmation Emailed
Mar 7, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 6, 2024
Allowed Principal Register - Sou Accepted
Mar 5, 2024
Teas/Email Correspondence Entered
Mar 5, 2024
Correspondence Received In Law Office
Mar 5, 2024
Teas/Email Correspondence Entered
Mar 5, 2024
Correspondence Received In Law Office
Mar 5, 2024
Assigned To Lie
Sep 13, 2023
Teas Post Publication Amendment Received
May 17, 2023
Teas Response To Office Action Received
Feb 22, 2023
Notification Of Non-Final Action E-Mailed
Feb 22, 2023
Non-Final Action E-Mailed
Feb 22, 2023
Su - Non-Final Action - Written
Jan 10, 2023
Statement Of Use Processing Complete
Dec 8, 2022
Use Amendment Filed
Jan 9, 2023
Case Assigned To Intent To Use Paralegal
Dec 8, 2022
Teas Statement Of Use Received
May 27, 2022
Notice Of Approval Of Extension Request E-Mailed
May 25, 2022
Sou Extension 1 Granted
May 25, 2022
Sou Extension 1 Filed
May 25, 2022
Sou Teas Extension Received
Dec 14, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 19, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 19, 2021
Published For Opposition
Sep 29, 2021
Notification Of Notice Of Publication E-Mailed
Sep 11, 2021
Approved For Pub - Principal Register
Sep 11, 2021
Examiner's Amendment Entered
Sep 11, 2021
Notification Of Examiners Amendment E-Mailed
Sep 11, 2021
Examiners Amendment E-Mailed
Sep 11, 2021
Examiners Amendment -Written
Sep 11, 2021
Notification Of Non-Final Action E-Mailed
Sep 11, 2021
Non-Final Action E-Mailed
Sep 11, 2021
Non-Final Action Written
Sep 5, 2021
Assigned To Examiner
May 14, 2021
New Application Office Supplied Data Entered
Feb 15, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24